drugset / Trial / NCT00972673
A Study of GW685698X in Healthy Japanese Male Subjects
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a randomized, double blind, placebo controlled, parallel-group, repeat dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled dose from a novel dry powder device in healthy Japanese male subjects.
Timeline
- Start
- 2008-09-24
- Primary completion
- 2008-12-19
- Completion
- 2008-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | 200 ug | Inhaled |
| Subject | Fluticasone Furoate | Other / unclassified | 400 ug | Inhaled |
| Subject | Fluticasone Furoate | Other / unclassified | 800 ug | Inhaled |